Poster Group 9

Total Page:16

File Type:pdf, Size:1020Kb

Poster Group 9 Abstracts S32 124 125 HLA ALLELES IN ISOLATED POPULATIONS FROM NORTH HLA-DPB1* POLYMORPHISMS IN GREEK POPULATION SPAIN: ORIGIN OF THE BASQUES AND THE ANCIENT IBERIANS. Katerina E. Tarassi, Diamanto I. Kouniaki, Theophilos I. Athanassiades, Chryssa A. Papasteriades. Pablo Sánchez-Velasco2, Eduardo Gómez-Casado1, Jorge Martínez-Laso1, Immunology - Histocompatibility Dept, Evangelismos Hospital, Juan Moscoso1, Jorge Zamora1, Ernesto Lowy1, Carlos Silvera-Redondo1, Athens, Greece. Alberto Cemborain2, Francisco Leyva-Cobián2, and Antonio Arnaiz-Villena1. 1Department of Immunology and Molecular Biology, Hosp. 12 de Octubre, Since the number of HLA-DPB1 identified alleles is continuously increasing Universidad Complutense, Madrid, Spain. E-mail: [email protected]. and their clinical relevance, particularly in Bone Marrow Transplantation, is 2Department of Immunology. Hospital Universitario Marqués de established, the aim of this work is to present the HLA-DPB1 polymorphism in Valdecilla. 39008 Santander, Spain. Greeks. The population studied consisted of 140 unrelated, unselected healthy individuals of Greek origin. Sixty-eight (68) of them were typed for HLA-A, -B, -DRB1, -DQA1 and -DQB1 alleles have been studied in three DPB1*0101-1901 using oligonucleotide typing, whereas 72 were typed for all relatively isolated populations of northern Spain from Cantabria (Pas Valleys known DPB1 alleles by PCR-SSOP and/or PCR-SSP. inhabitants or Pasiegos and Cabuernigos) and from the Basque Country (Arratia The DPB1* alleles detected are presented in the following table: Valley inhabitants). These populations have been compared to other neighbouring ones and other Mediterraneans by using neighbor-joining DPB1 Freq % DPB1 Freq % DPB1 Freq % dendrograms, plane genetic distances, correspondence and HLA haplotype (N=140) (N=140) (N=72) analyses. These populations are more related each other than to Spaniards and 0101 7.1 1101 5.7 2001 1.4 also are genetically close to North Africans. Pasiegos show a slight degree of 0201 40.0 1301 5.0 3101 1.4 admixture with central and western Europeans. The most feasible origin of these 0301 7.1 1401 1.4 3301 1.4 populations is regarded as being a remnant of the primitive Spanish population 0401 58.6 1601 2.1 3501 2.8 (ancient Iberians) or otherwise of North African refugees that could have 0402 33.6 1701 3.6 3701 1.4 occupied the area before their expulsion by the Catholic Kings after 1492 AD, 0501 1.4 3901 1.4 when North Africans definitively were expelled. The first theory is more favoured since there are no records of a permanent Muslim invasion in these 0801 0.7 5001 1.4 areas during Middle Ages. 0901 0.7 5101 1.4 1001 4.3 6001 1.4 Conclusions: In comparison to the data from the 11th and 12th IHW 1) DPB1*0201, 0401, 0402 are the most frequent alleles in Greeks, as in other Caucasians, but DPB1*0201 shows the highest frequency among all populations studied, 2) DPB1*1301, characterizing Blacks and Orientals, is presented in Greeks with the highest frequency among Caucasians (except Gypsy Spanish). So, it seems that DPB1* alleles distribution in Greeks show certain peculiarities, as we have also found in other HLA loci studied. Poster Group 9 - Immunogenetics of Disease 126 127 THE ORIGIN OF SOUTHERN SIBERIA TUVINIANS: A COORDINATED DOWNREGULATION OF APM COMPONENTS POPULATION WITH BOTH ORIENTAL AND CAUCASOID IN MHC CLASS I-DEFICIENT METASTATIC TUMOUR CHARACTERISTICS. VARIANTS IMMUNOSELECTED BY T LYMPHOCYTES Jorge Martínez-Laso2, Marina Sartakova1, Luis Allende2, Marisol Martinez, Angel M. Garcia-Lora, Ignacio Algarra*, Eva Jimenez and Vladimir Konenkov1, Juan Moscoso2, Carlos Silvera-Redondo2, Federico Garrido Serv. Analisis Clinicos, Hospital Univ. Virgen de las Nieves, Arancha Pacho2, Jorge Zamora2, Ernesto Lowy2, Eduardo Granada, Spain. *Dep. Ciencias de la Salud, Univ. de Jaén, Spain Gómez-Casado2, and Antonio Arnaiz-Villena2 1 Laboratory of Immunogenetics, Institute of Clinical Immunology, 630091 Our previous studies with the GR9 tumour model had shown that the MHC class Novosibirsk, Russia I phenotype of the metastatic tumour variants differs depending on the immune 2 Department of Immunology and Molecular Biology, H. 12 de status of the host: MHC class I-negative in immunocompetent BALB/c mice Octubre, Universidad Complutense, Madrid, Spain. E-mail: and MHC class I-positive in immunodeficient (nu/nu) mice. The results showed that in this tumour model the major factor contributing to the appearance of [email protected]. MHC class I-negative tumour variants is T cell immunoselection. HLA class I and class II alleles have been studied for the first time in the To explore the molecular mechanisms involved in the origin of these MHC Turkish-speaking Tuvinian population, which lives in Russia, North of class I-deficient tumour variants in our fibrosarcoma model, we analyzed the Mongolia and close to the Altai mountains. Comparisons have been done with expression of different components of the MHC class I antigen-processing about 11000 chromosomes from other worldwide populations, and extended machinery (APM). haplotypes, genetic distances, neighbour joining dendrograms and The MHC class I stability assays at 26ºC in the presence of exogenous 2- correspondence analyses have been calculated. Tuvinians show an admixture of microglobulin showed a partially recovered the cell surface expression of H-2 Mongoloid and Caucasoid characters, the latter probably coming from the class I molecules. Semiquantitative RT-PCR of different APM components ancient Kyrgyz background or, less feasibly, more recent Russian Caucasoid showed the constitutive expression of TAP-1, TAP-2, LMP-2, LMP-7, LMP-10, admixture. However, Siberian population traits are not found and thus Tuvinians tapasin and calnexin was downregulated in the B9 tumour clone as well as in all are closer to Central Asian populations. Siberians are more related to Na-Dene metastatic nodes obtained from immunocompetent BALB/c mice. Interestingly, and Eskimo American Indians; Amerindians (from nowadays Iberian-America) this was not the case for the nu/nu BALB/c-derived metastases. In conclusion, a are not related to any other group, including Pacific Islanders, Siberians or other coordinate transcriptional downregulation of multiple components of the APM American Indians. The `more than one wave' model for the peopling of the is responsible for the absence of H-2 class I antigen surface expression in Americas is supported. metastatic nodes generated in immunocompetent BALB/c mice. Genes and Immunity Abstracts S33 128 129 DIFFERENT IMMUNOGENICITY AND PATTERN OF LOCAL MOLECULAR MECHANISMS INVOLVED IN THE TOTAL GROWTH IN METASTATIC TUMOUR VARIANTS THAT LOSS OF HLA CLASS I IN COLORECTAL TUMORS: 2M ARE/ARE NOT IMMUNOSELECTED BY T LYMPHOCYTES INACTIVATION AND LMP7 DOWNREGULATION. Marisol Martinez, Angel M. Garcia-Lora, Ignacio Algarra*, Eva Jimenez and Carmen M. Cabrera, Pilar Jiménez, Teresa Cabrera, Francisco Ruiz- Federico Garrido Servicio de Analisis Clinicos, Hospital Universitario Virgen de las Cabello, Federico Garrido. Servicio de Análisis Clínicos. Hospital Nieves, Granada, Spain. *Departamento de Ciencias de la Salud, Universitario Virgen de las Nieves. Granada. Spain. Universidad de Jaén, Jaén, Spain The mechanisms to produce loss of MHC class I expression, in different types of tumors are partially known. Accordingly, we have studied colorectal tumors We previously reported that metastatic cell lines obtained in immunocompetent to elucidate the specific mechanisms evading T-cell immunoresponse. BALB/c mice have a H-2 class I-negative phenotype similar to that of the We have selected tumors with total loss of MHC class I expression by inducing fibrosarcoma tumour cell clone from which they derived. In contrast studying 124 colorectal tumors with immunohistochemical staining with anti when immunodeficient (nu/nu) BALB/c mice were used to produce metastases, HLA monoclonal antibodies (mAb). 14 tumors out of 124 (11%) exibit a 100% of the metastasis-derived cell lines were H-2 class I-positive for Kd, Dd phenotype with HLA class I total loss. Microsatellite instability (MSI) analysis and Ld molecules. The results showed that in this tumour model the major was also carry out in the same tumor samples. The expression of β2- factor contributing to the appearance of MHC class I-negative tumour variants is microglobulin, HLA-A, B, and C, TAP1, TAP2, LMP2, and LMP7 were T cell immunoselection. analysed using RT-PCR in microdissected tumor samples. 4 out of 14 MSI To determine the biological behaviour of these metastatic tumour variants we positive (MSI+) and W6/32 mAb negative tumors, showed biallellic inactivation performed local growth and immunogenicity studies. Different metastatic cell of β2m and accumulation of HLA heavy chain in the cytoplasm. MSI negative lines were injected subcutaneously into the footpad in syngeneic (MSI-)/W6/32 mAb negative tumors presented alterations in the expression of immunocompetent BALB/c mice. components of the antigen processing machinery (APM). 9 out of 10 tumor The results showed a different pattern of local growth: H-2 positive metastatic samples showed downregulation of LMP7 gene, and 4 out 10 presented TAP2 cell lines derived from nu/nu mice grew slowly, reaching a maximum of 5 mm disregulation. This group apparently expressed normal levels of heavy chain and of diameter after 15 days, then regressing and been rejected after a short period 2m proteins. of time (25 days). The H-2 negative metastatic cells (derived from
Recommended publications
  • Single Nucleotide Polymorphism (SNP)
    Aquaculture Genome Technologies Zhanjiang (John) Liu Copyright © 2007 by Blackwell Publishing Chapter 6 Single Nucleotide Polymorphism (SNP) Zhanjiang Liu Single nucleotide polymorphism (SNP) describes polymorphisms caused by point mutations that give rise to different alleles containing alternative bases at a given nucleotide position within a locus. Such sequence differences due to base substitu- tions have been well characterized since the beginning of DNA sequencing in 1977, but the ability to genotype SNPs rapidly in large numbers of samples was not possible until several major technological advances in the late 1990s. With the development of the TaqMan technology, gene chip technology, pyrosequencing, and MALDI-TOF, which is matrix-assisted laser desorption ionization-time of flight mass spectrometry (Haff et al. 1997, Tost et al. 2005), SNPs are again becoming a focal point in molecular marker development because they are the most abundant polymorphism in any organ- ism (as shown in Table 6.1), adaptable to automation, and reveal hidden polymor- phism not detected with other markers and methods. SNP markers are regarded by many as the projected markers of choice for the future. In this chapter, I will summa- rize methods for SNP discovery, review the traditional approaches for SNP genotyp- ing and their principles, present several major platforms for SNP genotyping using recently developed technologies, and discuss the pros and cons of SNP markers for aquaculture genome research. What Are SNP Markers and Why Are They the Future Markers of Choice? SNP can be defined as base variation at any site of the genome among individuals, or an alternative base at a given DNA site (Figure 6.1).
    [Show full text]
  • Genetic, Epidemiological and Biological Analysis of Interleukin-10
    Genes and Immunity (2009) 10, 174–180 & 2009 Macmillan Publishers Limited All rights reserved 1466-4879/09 $32.00 www.nature.com/gene ORIGINAL ARTICLE Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for À819C/T in leprosy susceptibility AC Pereira1,5, VN Brito-de-Souza1,5, CC Cardoso2, IMF Dias-Baptista1, FPC Parelli1,3, J Venturini1,3, FR Villani-Moreno1, AG Pacheco4 and MO Moraes2 1Instituto Lauro de Souza Lima, Bauru, Sa˜o Paulo, Brazil; 2Laborato´rio de Hansenı´ase, Departamento de Micobacterioses, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil; 3Tropical Diseases Area, Botucatu Medical School, Sao Paulo State University, UNESP, Botucatu, Sa˜o Paulo, Brazil and 4Departamento de Epidemiologia e Me´todos Quantitativos em Sau´de (DEMQS), Escola Nacional de Sau´de Pu´blica (ENSP)/PROCC, FIOCRUZ, Rio de Janeiro, Brazil Leprosy is a complex infectious disease influenced by genetic and environmental factors. The genetic contributing factors are considered heterogeneous and several genes have been consistently associated with susceptibility like PARK2, tumor necrosis factor (TNF), lymphotoxin-a (LTA) and vitamin-D receptor (VDR). Here, we combined a case–control study (374 patients and 380 controls), with meta-analysis (5 studies; 2702 individuals) and biological study to test the epidemiological and physiological relevance of the interleukin-10 (IL-10) genetic markers in leprosy. We observed that the À819T allele is associated with leprosy susceptibility either in the case–control or in the meta-analysis studies. Haplotypes combining promoter single-nucleotide polymorphisms also implicated a haplotype carrying the À819T allele in leprosy susceptibility (odds ratio (OR) ¼ 1.40; P ¼ 0.01).
    [Show full text]
  • Application of NGS Technology in Understanding the Pathology of Autoimmune Diseases
    Journal of Clinical Medicine Review Application of NGS Technology in Understanding the Pathology of Autoimmune Diseases Anna Wajda 1 , Larysa Sivitskaya 2,* and Agnieszka Paradowska-Gorycka 1 1 Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland; [email protected] (A.W.); [email protected] (A.P.-G.) 2 Institute of Genetics and Cytology, National Academy of Sciences of Belarus, 220072 Minsk, Belarus * Correspondence: [email protected] Abstract: NGS technologies have transformed clinical diagnostics and broadly used from neonatal emergencies to adult conditions where the diagnosis cannot be made based on clinical symptoms. Autoimmune diseases reveal complicate molecular background and traditional methods could not fully capture them. Certainly, NGS technologies meet the needs of modern exploratory research, diagnostic and pharmacotherapy. Therefore, the main purpose of this review was to briefly present the application of NGS technology used in recent years in the understanding of autoimmune diseases paying particular attention to autoimmune connective tissue diseases. The main issues are presented in four parts: (a) panels, whole-genome and -exome sequencing (WGS and WES) in diagnostic, (b) Human leukocyte antigens (HLA) as a diagnostic tool, (c) RNAseq, (d) microRNA and (f) microbiome. Although all these areas of research are extensive, it seems that epigenetic impact on the development of systemic autoimmune diseases will set trends for future studies on this area. Citation: Wajda, A.; Sivitskaya, L.; Keywords: next-generation sequencing; autoimmune diseases; autoimmune connective tissue dis- Paradowska-Gorycka, A. Application eases; HLA; microRNA; microbiome of NGS Technology in Understanding the Pathology of Autoimmune Diseases. J. Clin.
    [Show full text]
  • IMGT-Choreography for Immunogenetics and Immunoinformatics
    In Silico Biology 5 (2005) 45–60 45 IOS Press IMGT-Choreography for Immunogenetics and Immunoinformatics Marie-Paule Lefranc∗, Oliver Clement,´ Quentin Kaas, Elodie Duprat, Patrick Chastellan, Isabelle Coelho, Kora Combres, Chantal Ginestoux, Veronique´ Giudicelli, Denys Chaume and Gerard´ Lefranc IMGT, the international ImMunoGeneTics information system , Universite´ Montpellier II, Laboratoire d’ImmunoGen´ etique´ Moleculaire´ LIGM, UPR CNRS 1142, Institut de Gen´ etique´ Humaine IGH, 141 rue de la Cardonille, 34396 Montpellier Cedex 5, France Tel.: +33 4 99 61 99 65; Fax: +33 4 99 61 99 01 Edited by H. Michael; received 11 September 2004; revised and accepted 14 December 2004; published 24 December 2004 ABSTRACT: IMGT, the international ImMunoGeneTics information system (http://imgt.cines.fr), was created in 1989 at Montpellier, France. IMGT is a high quality integrated knowledge resource specialized in immunoglobulins (IG), T cell receptors (TR), major histocompatibility complex (MHC) of human and other vertebrates, and related proteins of the immune system (RPI) which belong to the immunoglobulin superfamily (IgSF) and MHC superfamily (MhcSF). IMGT provides a common access to standardized data from genome, proteome, genetics and three-dimensional structures. The accuracy and the consistency of IMGT data are based on IMGT-ONTOLOGY, a semantic specification of terms to be used in immunogenetics and immunoinformatics. IMGT-ONTOLOGY has been formalized using XML Schema (IMGT-ML) for interoperability with other information systems. We are developing Web services to automatically query IMGT databases and tools. This is the first step towards IMGT-Choreography which will trigger and coordinate dynamic interactions between IMGT Web services to process complex significant biological and clinical requests.
    [Show full text]
  • Multiple Sclerosis: Shall We Target CD33?
    G C A T T A C G G C A T genes Article Multiple Sclerosis: Shall We Target CD33? Vasileios Siokas 1, Zisis Tsouris 1, Athina-Maria Aloizou 1 , Christos Bakirtzis 2, Ioannis Liampas 1 , Georgios Koutsis 3 , Maria Anagnostouli 4 , Dimitrios P. Bogdanos 5, Nikolaos Grigoriadis 2, Georgios M. Hadjigeorgiou 1,6 and Efthimios Dardiotis 1,* 1 Laboratory of Neurogenetics, Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece; [email protected] (V.S.); [email protected] (Z.T.); [email protected] (A.-M.A.); [email protected] (I.L.); [email protected] (G.M.H.) 2 Multiple Sclerosis Center, B’ Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, GR54636 Thessaloniki, Greece; [email protected] (C.B.); [email protected] (N.G.) 3 Neurogenetics Unit, 1st Department of Neurology, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, Vassilissis Sofias 72-74 Ave, 11528 Athens, Greece; [email protected] 4 Multiple Sclerosis and Demyelinating Diseases Unit and Immunogenetics Laboratory, 1st Department of Neurology, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 115 28 Athens, Greece; [email protected] 5 Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece; [email protected] 6 Department of Neurology, Medical School, University of Cyprus, 1678 Nicosia, Cyprus * Correspondence: [email protected]; Tel.: +30-241-350-1137 Received: 23 September 2020; Accepted: 5 November 2020; Published: 12 November 2020 Abstract: Background: Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS).
    [Show full text]
  • Course of Study M. Sc. in Molecular & Human Genetics
    Course of Study M. Sc. in Molecular & Human Genetics DISTRIBUTION OF DIFFERENT COURSES AND CREDITS IN VARIOUS SEMESTERS Semester-I Course Code Title Credits MGM101 Transmission Genetics 2 MGM102 Molecular Genetics 3 MGM103 Basic Human Genetics 3 MGM104 Cytogenetics 2 MGM105 Biochemistry 3 MGM106 Cell Biology 3 MGM107 Lab work based on courses MGM101 &MGM102 2 MGM108 Lab work based on courses MGM103 & MGM104 2 MGM109 Lab work based on courses MGM105 & MGM106 2 Total 22 Semester-II Course Code Title Credits MGM201 DNA Technology & Genetic Engineering 3 MGM202 Bioinformatics and Biotechniques 3 MGM203 Model Genetic Systems 2 MGM204 Genomic Instability and Cancer 3 MGM205 Human Genome 3 MGM206 Reproductive Genetics 2 MGM207 Lab work based on courses MGM201 & MGM202 2 MGM208 Lab work based on courses MGM203 & MGM204 2 MGM209 SWAYAM Course 2 Total 22 Semester-III Course Code Title Credits MGM301 Human Molecular Genetics 3 MGM302 Clinical Genetics 3 MGM303 Developmental Genetics 3 MGM304 Immunogenetics 3 MGM305 Population & Evolutionary Genetics 2 MGM306 Lab work based on courses MGM301 & MGM302 2 MGM307 Lab work based on courses MGM303 & MGM304 2 MGM308 SWAYAM Course 2 Total 20 Semester-IV Course Code Title Credits MGM401 Neurogenetics 3 MGM402 Genetic Counseling and Intellectual Property Rights 2 MGM403 Lab work based on course MGM401 1 MGM404 Seminar & Formulation of Research Project 2 MGM405 Comprehensive Viva-voce 2 MGM406 Dissertation 6 Total 16 Grand Total 80 SEMESTER - I MGM101: Transmission Genetics Credits: 2 Lecture hours 1. Introduction to Genetics 1 2.Mendelism 5 2.1.Mendel and his experiments 2.2.Law of segregation 2.3.Law of independent assortment 2.4.Application of laws of probability (product rule, sum rule) 2.5.
    [Show full text]
  • GENETICS of LIVER DISEASE: IMMUNOGENETICS and DISEASE Gut: First Published As 10.1136/Gut.2003.031732 on 11 March 2004
    RECENT ADVANCES IN CLINICAL PRACTICE GENETICS OF LIVER DISEASE: IMMUNOGENETICS AND DISEASE Gut: first published as 10.1136/gut.2003.031732 on 11 March 2004. Downloaded from PATHOGENESIS 599 PTDonaldson Gut 2004;53:599–608. doi: 10.1136/gut.2003.031732 nderstanding the genetic basis of ‘‘complex disease’’ has been heralded as one of the major challenges of the post genome era.1 However what are ‘‘complex diseases’’ and how will understanding the genetics of such diseases advance medical science? There has been a U 2 great deal of ‘‘hype’’ about the potential of the human genome mapping project. The three major claims are that this information will: (a) be used in diagnosis; (b) provide useful prognostic indices for disease management (including the development of individualised treatment regimens, based on the findings of both immunogenetic and pharmacogenetic studies); and (c) provide insight into the pathogenesis of these diseases. Of these three objectives the last has the greatest potential and is the least exaggerated claim. In this review I shall highlight major associations, discuss some of the practical issues that arise, and outline how current knowledge of the immunogenetic basis of chronic liver disease is beginning to inform the debate about disease pathogenesis. c AN INTRODUCTION TO COMPLEX TRAITS Complex traits are defined as those where inheritance does not follow a Mendelian (that is, simple) pattern. This is not a new science; studies of complex traits were first performed in the mid-20th century. However, in the 21st century, the prevailing language has changed. Previously complex traits were called ‘‘polygenic’’ (involving more than one gene), multifactorial (depending on the interaction of the host genome and one or more environmental factors), or oligogenic (whereby individual mutations in several different genes in one or more common pathways lead to the same clinical syndrome but each patient with the disease may possess a single disease causing mutation only) (see box 1).
    [Show full text]
  • Combatting Disease Using Genetics
    WHAT IS PIRBRIGHT DOING? Traditional methods for performing such modifications are time consuming and unreliable. At Pirbright, COMBATTING Mosquito-borne diseases researchers are now using the CRISPR/Cas9 system for vaccine development which makes the process Mosquitoes have the ability to carry and transmit quick, simple and efficient. This technique also allows DISEASE many deadly diseases that are responsible for millions multiple genes from different viruses to be inserted of deaths and billions of pounds of economic losses into a single vaccine to provide protection against every year, particularly in developing countries. USING GENETICS multiple diseases. Pirbright carries out research to understand how genetically Immunogenetics modified mosquitoes can Immunogenetics explores the link between the be used for the control of immune system and an animal’s genes. Understanding mosquito populations to the genes that control livestock immune responses can prevent diseases of both help us improve their resistance to disease. livestock and people. Experts at Pirbright have been working to understand One of the most promising Female Aedes aegypti the genes that control natural killer (NK) cells; one control techniques is known mosquito feeding of the first lines of defence against viral infection. as a gene drive. This is where the mosquito genome NK cells detect the presence of a virus using special is modified to decrease their ability to breed or receptor proteins on their surface. These attach to carry infections, and this modification is favourably signalling proteins on cells that have become infected, spread into a population at a faster rate than normal triggering the NK cell to kill the infected cell and inheritance.
    [Show full text]
  • Genetics and Epigenetics of Atopic Dermatitis: an Updated Systematic Review
    G C A T T A C G G C A T genes Review Genetics and Epigenetics of Atopic Dermatitis: An Updated Systematic Review 1,2, 1,2,3, 1,2,3, Maria J Martin y, Miguel Estravís y , Asunción García-Sánchez * , Ignacio Dávila 1,2,4 , María Isidoro-García 1,2,5,6 and Catalina Sanz 1,2,7 1 Institute for Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; [email protected] (M.J.M.); [email protected] (M.E.); [email protected] (I.D.); [email protected] (M.I-G.); [email protected] (C.S.) 2 Network for Cooperative Research in Health–RETICS ARADyAL, 37007 Salamanca, Spain 3 Department of Biomedical and Diagnostics Sciences, University of Salamanca, 37007 Salamanca, Spain 4 Department of Immunoallergy, Salamanca University Hospital, 37007 Salamanca, Spain 5 Department of Clinical Biochemistry, University Hospital of Salamanca, 37007 Salamanca, Spain 6 Department of Medicine, University of Salamanca, 37007 Salamanca, Spain 7 Department of Microbiology and Genetics, University of Salamanca, 37007 Salamanca, Spain * Correspondence: [email protected]; Tel.: +3-492-329-1100 These authors equally contribute to the manuscript. y Received: 12 March 2020; Accepted: 15 April 2020; Published: 18 April 2020 Abstract: Background: Atopic dermatitis is a common inflammatory skin disorder that affects up to 15–20% of the population and is characterized by recurrent eczematous lesions with intense itching. As a heterogeneous disease, multiple factors have been suggested to explain the nature of atopic dermatitis (AD), and its high prevalence makes it necessary to periodically compile and update the new information available. In this systematic review, the focus is set at the genetic and epigenetic studies carried out in the last years.
    [Show full text]
  • Single Nucleotide Polymorphisms of Immunity-Related Genes and Their Effects on Immunophenotypes in Different Pig Breeds
    G C A T T A C G G C A T genes Article Single Nucleotide Polymorphisms of Immunity-Related Genes and Their Effects on Immunophenotypes in Different Pig Breeds Ann Ying-An Chen 1,2 , Chao-Wei Huang 3, Shyh-Hwa Liu 4, An-Chi Liu 1 and Hso-Chi Chaung 1,2,* 1 Research Center for Animal Biologics, National Pingtung University of Science and Technology, Neipu, Pingtung 912, Taiwan; [email protected] (A.Y.-A.C.); [email protected] (A.-C.L.) 2 Department of Veterinary Medicine, National Pingtung University of Science and Technology, Neipu, Pingtung 912, Taiwan 3 Department of Tropical Agriculture and International Cooperation, National Pingtung University of Science and Technology, Neipu, Pingtung 912, Taiwan; [email protected] 4 Department of Animal Science, National Pingtung University of Science and Technology, Neipu, Pingtung 912, Taiwan; [email protected] * Correspondence: [email protected] Abstract: Enhancing resistance and tolerance to pathogens remains an important selection objective in the production of livestock animals. Single nucleotide polymorphisms (SNPs) vary gene expression at the transcriptional level, influencing an individual’s immune regulation and susceptibility to diseases. In this study, we investigated the distribution of SNP sites in immune-related genes and their correlations with cell surface markers of immune cells within purebred (Taiwan black, Duroc, Landrace and Yorkshire) and crossbred (Landrace-Yorkshire) pigs. Thirty-nine SNPs of immune- related genes, including 11 cytokines, 5 chemokines and 23 Toll-like receptors (TLRs) (interferon-α Citation: Chen, A.Y.-A.; Huang, and γ (IFN-α, γ), tumor necrosis factor-α (TNF-α), granulocyte-macrophage colony-stimulating C.-W.; Liu, S.-H.; Liu, A.-C.; Chaung, factor (GM-CSF), Monocyte chemoattractant protein-1 (MCP-1) and TLR3, TLR4, TLR7, TLR8, and H.-C.
    [Show full text]
  • Division of Immunogenetics Division of Immunogenetics
    DIVISION OF IMMUNOGENETICS diVision of ImmunoGenetics Mission The Division of Immunogenetics is committed to providing basic science support aimed at better understanding the etio-pathogenesis of pediatric diseases to more efficiently and correctly diagnose, prevent, and possibly 136 better treat them. 137 DEPARTMENT OF PEDIATRICS 2012 ANNUAL REPORT DEPARTMENT OF PEDIATRICS 2012 ANNUAL REPORT DIVISION OF IMMUNOGENETICS DIVISION OF IMMUNOGENETICS facultY AND staff To block auto-immunity, without the use of immunosuppressant, Nick Giannoukakis and Massimo Trucco have success- fully completed a National Institutes of Health (NIH)-funded, U.S. Food and Drug Administration (FDA)-approved Massimo Trucco, MD Yong Fan, PhD Steven Ringquist, PhD phase I clinical trial that was designed to test the safety of a treatment in which autologous DC—rendered functionally Hillman Professor of Research Assistant Professor Research Assistant Professor immature by exposing them to CD40, CD80, and CD86 antisense oligodeoxyribonucleotides (AS-ODN) to reduce Pediatric Immunology costimulatory molecule levels at their surface—were administered to T1D patients with established disease. Leukocytes Nick Giannoukakis, PhD William Rudert, MD, PhD of the patient were obtained by apheresis, and DCs were then isolated and expanded. DC engineered in GMP facilities Suzanne Bertera, PhD Associate Professor Research Associate Professor to express low levels of CD40, CD80, and CD86 were then injected into the patient by intradermal administration at an Research Assistant Professor Jing He, MD, PhD Tatyana Votyakova, MD, PhD anatomical site proximal to the pancreas. DCs then migrate to the nearest (i.e., pancreatic) lymph nodes, where they are Rita Bottino, PhD Research Assistant Professor Research Assistant Professor able to interrupt the vicious circle that maintains islet-specific inflammation (i.e., insulitis).
    [Show full text]
  • Immunogenetics and Genomics
    IMMUNOLOGY Immunology Immunogenetics and genomics Adrian V S Hill Immunogenetic analysis of disease susceptibility has been encouraged by the identification of strong HLA associations with several diseases of uncertain cause. Weaker HLA associations exist with a large number of infectious and non- infectious diseases and the mechanisms of these effects are beginning to be uncovered. Extensive analyses of non-HLA immunogenetic variants have also been undertaken and associations with a variety of genes identified. Genetic linkage analysis of multicase families has recently identified new major susceptibility loci for a few immunologically determined common diseases. However, the greatest potential for the future lies in genome-wide searches for susceptibility genes that individually might have quite modest effects but cumulatively have a large impact on individual risk. This new era of immunogenomics promises to provide key insights into disease pathogenesis and identify multiple molecular targets for intervention strategies. The explosion of genetic data emerging from genomics and substantial. A few investigators have also estimated the size high-throughput sequencing is generating unprecedented of the genetic component of variable immune responses and opportunities for defining the genetic basis of susceptibility estimated the overall effect of major histocompatibility to complex diseases. Although most of the important complex (MHC) and non-MHC genes.2 A frequently used monogenic disorders have yielded to the power of modern measure of the size of the genetic component of disease molecular approaches, progress in unravelling the genetic susceptibility is the sibling risk, which is defined as the ratio basis of common multifactorial diseases has been slower. of the disease risk in a sibling of an affected individual to the Simple evolutionary considerations suggest that the genetic general population risk.
    [Show full text]